CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $274,800
- in 1 filing
Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Lonial Sagar Director | Grant or award · Stock Tracking Unit | +8,325 | 8,325 | ||
| 2025-09-11 | Lonial Sagar Director | Sale | −20,852 | $32.24 | $672K | 94,061 |
| 2025-06-12 | Lonial Sagar Director | Grant or award | +14,718 | 114,913 | ||
| 2024-11-11 | Lonial Sagar Director | Sale | −5,000 | $30.44 | $152K | 100,195 |
| 2024-06-20 | Lonial Sagar Director | Sale | −16,348 | $16.87 | $276K | 105,195 |
| 2024-06-19 | Lonial Sagar Director | Grant or award | +22,250 | 121,543 | ||
| 2024-06-17 | Lonial Sagar Director | Sale | −9,585 | $16.39 | $157K | 99,293 |
| 2024-03-13 | Lonial Sagar Director | Sale | −5,000 | $15.94 | $80K | 108,878 |
| 2023-09-28 | Lonial Sagar Director | Grant or award | −20,000 | 113,878 | ||
| 2023-06-23 | Lonial Sagar Director | Sale | −34,854 | $23.37 | $815K | 93,878 |
| 2022-07-20 | Lonial Sagar Director | Grant or award | +43,732 | 128,732 | ||
| 2021-06-18 | Lonial Sagar Director | Grant or award | +20,000 | 85,000 | ||
| 2020-06-22 | Lonial Sagar Director | Grant or award | +65,000 | 65,000 |
Page 1 of 1 · 13 trades